EMEA-000455-PIP02-10-M04

Key facts

Invented name
Brintellix
Active substance
Vortioxetine
Therapeutic area
Psychiatry
Decision number
P/0234/2018
PIP number
EMEA-000455-PIP02-10-M04
Pharmaceutical form(s)
  • Film-coated tablet
  • Age appropriate oral liquid dosage form
Condition(s) / indication(s)
Treatment of major depressive disorder
Route(s) of administration
Oral use
Contact for public enquiries
H. Lumdbeck A/S

E-mail: vana@lundbeck.com
Tel.  +45 3083 3413

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating